PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: PEPPI Pharmacies.
- Who it may be relevant to
- Registry conditions: HIV Prevention, HIV Pre-exposure Prophylaxis, Access and Linkage to Healthcare, Technology Use. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Impact of PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)
Overview
The goal of this clinical trial is to learn if use of the PEPPI software can improve pharmacist-provided HIV prevention (PEP/PrEP) services. The main questions it aims to answer are: 1. Does the PEPPI software make it easier for pharmacists to provide PEP/PrEP services in their pharmacy? 2. Does the PEPPI software make it easier for patients to access PEP/PrEP? Researchers will compare pharmacists' implementation and patients' access when using the PEPPI software and when not using the PEPPI software to see if the software improves implementation and access. Participants will include pharmacists and patients. Pharmacists will be asked to provide PEP/PrEP services as normal while using the PEPPI software. Patients will be asked to receive PEP/PrEP services from a pharmacist as normal, while using the PEPPI software.
Interventions
- Other PEPPI Pharmacies
We will enroll 10 community pharmacies. These 10 pharmacies will continue to provide PEP/PrEP services as normal for several months (control). Then, we will introduce the first phase of the intervention: the minimally viable product (MVP) version of the PEPPI software. The second phase of the intervention will use the enhanced version of the PEPPI software. The pharmacies will continue to provide PEP/PrEP services while using the PEPPI software in place of any paper or electronic processes that
Primary outcome measures
- Implementation - Service Characteristics Number of Pharmacists [Time frame: up to 12 months]
- Implementation - Service Characteristics Number of Pharmacy Staff [Time frame: up to 12 months]
- Implementation - Service Characteristics Cash Pay [Time frame: up to 12 months]
- Implementation - Service Characteristics Insurance Billing [Time frame: up to 12 months]
- Implementation - Proctor Implementation Outcomes [Time frame: up to 12 months]
Secondary outcome measures (1)
- Access to Care [Time frame: up to 12 months]
Eligibility criteria
PHARMACIST Participants
Inclusion criteria
- 18 years of age or older
- Provide, or willing to provide, PEP/PrEP services in a participating pharmacy
- Use the PEPPI software to provide birth control services
Exclusion criteria
- None
PATIENT Participants
Inclusion criteria
- 18 years of age or older
- Seek PEP or PrEP services at a participating pharmacy
- Use the PEPPI software to receive PEP/PrEP services at a participating pharmacy
Exclusion criteria
- NONE
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Health services research
Study locations
United States · 1 center
- EmpoweRx, Inc — Del Mar
Identifiers
NCT: NCT07683117 · R44MH142152 · R44MH142152